Business
Immuron share price shoots 90% higher on potential COVID-19 treatment news – Motley Fool Australia
The Immuron Limited (ASX: IMC) share price has shot 90% higher today following a release regarding the effect of its flagship drug Travelan on Covid-19.
The Immuron Limited (ASX: IMC) share price is up by 89.80% to 46 cents per share this morning on news that Immuron’s product IMM-124E has neutralising activity against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19.
This follows on from another positive announcement yesterday that the U.S. Food and Drug Administration (FDA) provided guidance about the development pathway for Immuron’s new oral therapeutic drugs.
What sent Immuron’s share price …
-
General16 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News22 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Noosa News20 hours agoMore children’s sand products from Kmart and Target recalled over asbestos contamination fears
-
Noosa News20 hours agoBurgess Creek to go weed free